SCHEMBL13870817

SCHEMBL13870817

COc1cc2cc(C)ccc2nc1-c1cc(C)cc(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 2/20 0.44
▸ PDGFRA P16234 2/20 0.44
▸ CYP1A2 P05177 2/20 0.41
▸ PSMB5 P28074 1/20 0.41
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALOX5 P09917 2/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ ACHE P22303 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ NCK1 P16333 1/20 0.39
▸ BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14500804 0.91 MEN1 (0.45) PDGFRBPDGFRACYP1A2PSMB5MEN1
SCHEMBL14500805 0.89 PDGFRB (0.53) PDGFRBPDGFRACYP1A2PSMB5MEN1
SCHEMBL14500803 0.88 PSMB5 (0.45) PDGFRBPDGFRACYP1A2PSMB5MEN1
SCHEMBL13647152 0.87 CYP1A2 (0.42) PDGFRBPDGFRACYP1A2MEN1KMT2A
SCHEMBL13399629 0.86 PDGFRB (0.47) PDGFRBPDGFRAHTTPDE3BPDE3A
SCHEMBL13870825 0.84 MEN1 (0.41) PDGFRBPDGFRAMEN1KMT2AGAA
SCHEMBL13870821 0.84 RORC (0.40) PDGFRBPDGFRAKMT2AHTT
SCHEMBL13870819 0.84 PSMB5 (0.37) PDGFRBPDGFRACYP1A2PSMB5MEN1
SCHEMBL13870826 0.82 PDGFRB (0.39) PDGFRBPDGFRAKDM4EL3MBTL1ACHE
SCHEMBL4097200 0.81 PDE10A (0.50) CYP1A2PSMB5MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023489-B2 Red phosphorescent compounds and organic electroluminescent devices using the same LG DISPLAY CO., LTD. (KR) 2015-05-05 — — US disclosed
US-9023489-B2 Red phosphorescent compounds and organic electroluminescent devices using the same LG DISPLAY CO., LTD. (KR) 2015-05-05 — — US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed
US-20070104980-A1 Red phosphorescent compounds and organic electroluminescent devices using the same LG DISPLAY CO., LTD. (KR) 2007-05-10 — — US disclosed
US-20070104980-A1 Red phosphorescent compounds and organic electroluminescent devices using the same LG DISPLAY CO., LTD. (KR) 2007-05-10 — — US disclosed
EP-1783132-A1 Red phosphorescent compounds and organic electromuninescent devices using the same LG Electronics Inc. (KR) 2007-05-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 PDGFRB 1748/4885PDGFRA 1137/4885CYP1A2 3387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback